Gene therapy progress and prospects: Electroporation and other physical methods

Gene Therapy

Volumn 11, Issue 18, 2004, Pages 1363-1369

  Wells, D J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Gene transfer; Hydrodynamic; Plasmid DNA; Skeletal muscle; Ultrasound; Vascular

Indexed keywords

ADENOVIRUS VECTOR; BLEOMYCIN; CELL SURFACE PROTEIN; DNA VACCINE; DYSTROPHIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; LIVER ENZYME; PLASMID DNA; PROOPIOMELANOCORTIN; SMALL INTERFERING RNA; VACCINIA VACCINE; VIRUS PROTEIN; VIRUS VECTOR;

ANTINEOPLASTIC ACTIVITY; BECKER MUSCULAR DYSTROPHY; BLADDER DISEASE; CELLULAR IMMUNITY; CLINICAL TRIAL; DRUG POTENTIATION; DUCHENNE MUSCULAR DYSTROPHY; ELECTROPORATION; GENE GUN; GENE TRANSFER; GENETIC TRANSFECTION; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; IN VIVO STUDY; LASER; MAGNETIC FIELD; MELANOMA; METHODOLOGY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; ORGAN PERFUSION; PAIN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; TH1 CELL; TH2 CELL; VIRAL GENE DELIVERY SYSTEM;

GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; PLASMIDS;

EID: 4644371368     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302337     Document Type: Review

References (84)

1. Comerota AJ et al. Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: preliminary results of a phase I trial. J Vasc Surg 2002; 35: 930-936.
2. Losordo DW et al. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 2002; 105: 2012-2018.
3. Gothelf A, Mir LM, Gehl J. Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev 2003; 29: 371-387.
4. Bigey P, Bureau MF, Scherman D. In vivo plasmid DNA electrotransfer. Curr Opin Biotechnol 2002; 13: 443-447.
5. Gehl J. Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand 2003; 177: 437-447.
6. McMahon JM, Wells DJ. Electroporation for gene transfer to skeletal muscles: current status. BioDrugs 2004; 18: 155-165.
7. Bloquel C, Fabre E, Bureau MF, Scherman D. Plasmid DNA electrotransfer for intracellular and secreted proteins expression: new methodological developments and applications. J Gene Med 2004; 6 (Suppl 1): S11-S23.
8. Golzio M, Teissie J, Rols MP. Direct visualization at the single-cell level of electrically mediated gene delivery. Proc Natl Acad Sci USA 2002; 99: 1292-1297.
9. Budker V et al. Hypothesis: naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process. J Gene Med 2000; 2: 76-88.
10. Bureau MF et al. Intramuscular plasmid DNA electrotransfer: biodistribution and degradation. Biochim Biophys Acta 2004; 1676: 138-148.
11. Zhang L, Nolan E, Kreitschitz S, Rabussay DP. Enhanced delivery of naked DNA to the skin by non-invasive in vivo electroporation. Biochim Biophys Acta 2002; 1572: 1-9.
12. Bureau MF et al. Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. Biochim Biophys Acta 2000; 1474: 353-359.
13. McMahon JM et al. Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase - increased expression with reduced muscle damage. Gene Therapy 2001; 8: 1264-1270.
14. Durieux AC, Bonnefoy R, Busso T, Freyssenet D. In vivo gene electrotransfer into skeletal muscle: effects of plasmid DNA on the occurrence and extent of muscle damage. J Gene Med 2004; 6: 809-816.
15. Dean DA et al. Electroporation as a method for high-level nonviral gene transfer to the lung. Gene Therapy 2003; 10: 1608-1615.
16. Ohashi S et al. Successful genetic transduction in vivo into synovium by means of electroporation. Biochem Biophys Res Commun 2002; 293: 1530-1535.
17. Lin CR et al. Electroporation for direct spinal gene transfer in rats. Neurosci Lett 2002; 317: 1-4.
18. Dezawa M et al. Gene transfer into retinal ganglion cells by in vivo electroporation: a new approach. Micron 2002; 33: 1-6.
19. Matsuda T, Cepko CL. Electroporation and RNA interference in the rodent retina in vivo and in vitro. Proc Natl Acad Sci USA 2004; 101: 16-22.
20. Wells KE et al. Enhanced in vivo delivery of antisense oligonucleotides to restore dystrophin expression in adult mdx mouse muscle. FEBS Lett 2003; 552: 145-149.
21. Heller LC, Coppola D. Electrically mediated delivery of vector plasmid DNA elicits an antitumor effect. Gene Therapy 2002; 9: 1321-1325.
22. Tamura T et al. Combination of IL-12 and IL-18 of electro-gene therapy synergistically inhibits tumor growth. Anticancer Res 2003; 23: 1173-1179.
23. Kishida T et al. Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice. Mol Ther 2003; 8: 738-745.
24. Liu F, Huang L. Electric gene transfer to the liver following systemic administration of plasmid DNA. Gene Therapy 2002; 9: 1116-1119.
25. Tollefsen S et al. Improved cellular and humoral immune responses against Mycobacterium tuberculosis antigens after intramuscular DNA immunisation combined with muscle electroporation. Vaccine 2002; 20: 3370-3378.
26. Zhang L et al. Accelerated immune response to DNA vaccines. DNA Cell Biol 2003; 22: 815-822.
27. Scheerlinck JP et al. In vivo electroporation improves immune responses to DNA vaccination in sheep. Vaccine 2004; 22: 1820-1825.
28. Tjelle TE et al. Monoclonal antibodies produced by muscle after plasmid injection and electroporation. Mol Ther 2004; 9: 328-336.
29. Fukuchi-Shimogori T, Grove EA. Neocortex patterning by the secreted signaling molecule FGF8. Science 2001; 294: 1071-1074.
30. Saito T, Nakatsuji N. Efficient gene transfer into the embryonic mouse brain using in vivo electroporation. Dev Biol 2001; 240: 237-246.
31. Tabata H, Nakajima K. Efficient in utero gene transfer system to the developing mouse brain using electroporation: visualization of neuronal migration in the developing cortex. Neuroscience 2001; 103: 865-872.
32. Wei F et al. Calmodulin regulates synaptic plasticity in the anterior cingulate cortex and behavioral responses: a microelectroporation study in adult rodents. J Neurosci 2003; 23: 8402-8409.
33. Wang Z et al. Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation. Gene Therapy 2004; 11: 711-721.
34. Zhang G et al. Hydroporation as the mechanism of hydrodynamic delivery. Gene Therapy 2004; 11: 675-682.
35. Andrianaivo F et al. Hydrodynamics-based transfection of the liver: entrance into hepatocytes of DNA that causes expression takes place very early after injection. J Gene Med 2004, online in advance of print.
36. Kobayashi N et al. Hepatic delivery of particulates in the submicron range by a hydrodynamics-based procedure: implications for particulate gene delivery systems. J Gene Med 2004; 6: 455-463.
37. Kobayashi N, Nishikawa M, Hirata K, Takakura Y. Hydrodynamics-based procedure involves transient hyperpermeability in the hepatic cellular membrane: implication of a nonspecific process in efficient intracellular gene delivery. J Gene Med 2004; 6: 584-592.
38. Ehrhardt A et al. Optimization of cis-acting elements for gene expression from nonviral vectors in vivo. Hum Gene Ther 2003; 14: 215-225.
39. Alino SF, Crespo A, Dasi F. Long-term therapeutic levels of human alpha-1 antitrypsin in plasma after hydrodynamic injection of nonviral DNA. Gene Therapy 2003; 10: 1672-1679.
40. Lewis DL et al. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat Genet 2002; 32: 107-108.
41. McCaffrey AP et al. RNA interference in adult mice. Nature 2002; 418: 38-39.
42. Maruyama H et al. High-level expression of naked DNA delivered to rat liver via tail vein injection. J Gene Med 2002; 4: 333-341.
43. Eastman SJ et al. Development of catheter-based procedures for transducing the isolated rabbit liver with plasmid DNA. Hum Gene Ther 2002; 13: 2065-2077.
44. Maruyama H et al. Kidney-targeted naked DNA transfer by retrograde renal vein injection in rats. Hum Gene Ther 2002; 13: 455-468.
45. Liu F, Lei J, Vollmer R, Huang L. Mechanism of liver gene transfer by mechanical massage. Mol Ther 2004; 9: 452-457.
46. Liu F, Nishikawa M, Clemens PR, Huang L. Transfer of full-length Dmd to the diaphragm muscle of Dmd(mdx/mdx) mice through systemic administration of plasmid DNA. Mol Ther 2001; 4: 45-51.
47. Zhang G et al. Efficient expression of naked DNA delivered intraarterially to limb muscles of nonhuman primates. Hum Gene Ther 2001; 12: 427-438.
48. Eggermont AM, de Wilt JH, ten Hagen TL. Current uses of isolated limb perfusion in the clinic and a model system for new strategies. Lancet Oncol 2003; 4: 429-437.
49. Herweijer H, Wolff JA. Progress and prospects: naked DNA gene transfer and therapy. Gene Therapy 2003; 10: 453-458.
50. Braun S. Duchenne muscular dystrophy gene therapy. Abstract Inv 26, ESGT 11th Annual Congress, November 14-17, 2003.
51. Liang KW et al. Restoration of dystrophin expression in mdx mice by intravascular injection of naked DNA containing full-length dystrophin cDNA. Gene Ther 2004; 11: 901-908.
52. Taniyama Y et al. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Therapy 2002; 9: 372-380.
53. Taniyama Y et al. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 2002; 105: 1233-1239.
54. Schratzberger P et al. Transcutaneous ultrasound augments naked DNA transfection of skeletal muscle. Mol Ther 2002; 6: 576-583.
55. Danialou G et al. Ultrasound increases plasmid-mediated gene transfer to dystrophic muscles without collateral damage. Mol Ther 2002; 6: 687-693.
56. Lu QL, Liang HD, Partridge T, Blomley MJ. Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage. Gene Therapy 2003; 10: 396-405.
57. Chen S et al. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol 2003; 42: 301-308.
58. Bekeredjian R et al. Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 2003; 108: 1022-1026.
59. Huber PE et al. Focused ultrasound (HIFU) induces localized enhancement of reporter gene expression in rabbit carotid artery. Gene Therapy 2003; 10: 1600-1607.
60. Miller DL, Song J. Tumor growth reduction and DNA transfer by cavitation-enhanced high-intensity focused ultrasound in vivo. Ultrasound Med Biol 2003; 29: 887-893.
61. Li T, Tachibana K, Kuroki M. Gene transfer with echo-enhanced contrast agents: comparison between Albunex, Optison, and Levovist in mice - initial results. Radiology 2003; 229: 423-428.
62. Pislaru SV et al. Optimization of ultrasound-mediated gene transfer: comparison of contrast agents and ultrasound modalities. Eur Heart J 2003; 24: 1690-1698.
63. Yamashita Y et al. In vivo gene transfer into muscle via electrosonoporation. Hum Gene Ther 2002; 13: 2079-2084.
64. Zeira E et al. Femtosecond infrared laser - an efficient and safe in vivo gene delivery system for prolonged expression. Mol Ther 2003; 8: 342-350.
65. Durieux AC, Bonnefoy R, Manissolle C, Freyssenet D. High-efficiency gene electrotransfer into skeletal muscle: description and physiological applicability of a new pulse generator. Biochem Biophys Res Commun 2002; 296: 443-450.
66. Scherer F et al. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Therapy 2002; 9: 102-109.
67. Chuang YC et al. Gene therapy for bladder pain with gene gun particle encoding pro-opiomelanocortin cDNA. J Urol 2003; 170: 2044-2048.
68. Kitagawa T et al. Advantages and limitations of particle-mediated transfection (gene gun) in cancer immuno-gene therapy using IL-10, IL-12 or B7-1 in murine tumor models. J Gene Med 2003; 5: 958-965.
69. Matsuno Y et al. Nonviral gene gun mediated transfer into the beating heart. ASAIO J 2003; 49: 641-644.
70. Yoshizawa J et al. Successful in utero gene transfer using a gene gun in midgestational mouse fetuses. J Pediatr Surg 2004; 39: 81-84.
71. Martiniuk F et al. Helios gene gun particle delivery for therapy of acid maltase deficiency. DNA Cell Biol 2002; 21: 717-725.
72. Dileo J, Miller Jr TE, Chesnoy S, Huang L. Gene transfer to subdermal tissues via a new gene gun design. Hum Gene Ther 2003; 14: 79-87.
73. Trimble C et al. Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe. Vaccine 2003; 21: 4036-4042.
74. Barfoed AM et al. Influence of routes and administration parameters on antibody response of pigs following DNA vaccination. Vaccine 2004; 22: 1395-1405.
75. Lima KM et al. Efficacy of DNA-hsp65 vaccination for tuberculosis varies with method of DNA introduction in vivo. Vaccine 2003; 22: 49-56.
76. Sasaki S et al. Adjuvant formulations and delivery systems for DNA vaccines. Methods 2003; 31: 243-254.
77. Zhu W, Thomas CE, Sparling PF. DNA immunization of mice with a plasmid encoding Neisseria gonorrhoeae PorB protein by intramuscular injection and epidermal particle bombardment. Vaccine 2004; 22: 660-669.
78. Liu MA. DNA vaccines: a review. J Intern Med 2003; 253: 402-410.
79. Paster W et al. In vivo plasmid DNA electroporation generates exceptionally high levels of epitope-specific CD8+ T-cell responses. Gene Therapy 2003; 10: 717-724.
80. Babiuk S et al. Electroporation improves the efficacy of DNA vaccines in large animals. Vaccine 2002; 20: 3399-3408.
81. Arruda VR et al. Sustained correction of hemophilia B phenotype following intravascular delivery of AAV vector to skeletal muscle. Mol Ther 2002; 5: S157.
82. Emani SM et al. Catheter-based intracoronary myocardial adenoviral gene delivery: importance of intraluminal seal and infusion flow rate. Mol Ther 2003; 8: 306-313.
83. Ding Z et al. A minimally invasive approach for efficient gene delivery to rodent hearts. Gene Therapy 2004; 11: 260-265.
84. Chen S et al. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol 2003; 42: 301-308.